Christy J. Oliger - 02 Jun 2021 Form 4 Insider Report for Sierra Oncology, Inc.

Role
Director
Signature
/s/ Christy J. Oliger; By: Mary Christina Thomson, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
04 Jun 2021, 13:59:11 UTC
Previous filing
21 May 2021
Next filing
14 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRRA Stock Option (right to buy) Award $0 +18,000 $0.000000 18,000 02 Jun 2021 Common Stock 18,000 $17.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest at the rate of 2.778% monthly, beginning on the one-month anniversary of the grant date, with 100% vested on the three-year anniversary of the grant date, subject to the provision of service by the Reporting Person to the Issuer on each vesting date.